Previous studies reported that DC-CIK cells therapy significantly increased the cells proportion of CD3+, CD4+, and the ratio of CD4+/CD8+ cells.[13,14] Furthermore, these improved tumor response in EC. This evidence concerns the gene CD4 and neoplasm.